Thomas Munk Laursen1. 1. National Centre for Register-Based Research, Aarhus University, Taasingegade 1, 8000 Aarhus C, Denmark. tml@ncrr.dk
Abstract
CONTEXT: Mortality rates among individuals with schizophrenia or bipolar disorder are elevated compared to the general population. OBJECTIVE: The objective was to estimate life-expectancy (average age at death) among these persons and make a comparison to people in the general population. METHODS: Life-expectancy was calculated by means of survival analysis techniques using the entire Danish population as a cohort. RESULTS: Life-expectancy was 18.7 years shorter for schizophrenic men compared to men in the general population. Corresponding numbers for schizophrenic women was 16.3 years, for bipolar men 13.6 years, and for bipolar women 12.1 years. CONCLUSIONS: Life-expectancy was much shorter in persons with schizophrenia or bipolar disorder. Excess mortality from physical diseases and medical conditions exerts a far greater influence on the curtailed life-expectancy, when compared against the impact of death by external causes.
CONTEXT: Mortality rates among individuals with schizophrenia or bipolar disorder are elevated compared to the general population. OBJECTIVE: The objective was to estimate life-expectancy (average age at death) among these persons and make a comparison to people in the general population. METHODS: Life-expectancy was calculated by means of survival analysis techniques using the entire Danish population as a cohort. RESULTS: Life-expectancy was 18.7 years shorter for schizophrenicmen compared to men in the general population. Corresponding numbers for schizophrenicwomen was 16.3 years, for bipolar men 13.6 years, and for bipolar women 12.1 years. CONCLUSIONS: Life-expectancy was much shorter in persons with schizophrenia or bipolar disorder. Excess mortality from physical diseases and medical conditions exerts a far greater influence on the curtailed life-expectancy, when compared against the impact of death by external causes.
Authors: Deepak K Sarpal; Miklos Argyelan; Delbert G Robinson; Philip R Szeszko; Katherine H Karlsgodt; Majnu John; Noah Weissman; Juan A Gallego; John M Kane; Todd Lencz; Anil K Malhotra Journal: Am J Psychiatry Date: 2015-08-28 Impact factor: 18.112
Authors: Suraj Sarvode Mothi; Neeraj Tandon; Jaya Padmanabhan; Ian T Mathew; Brett Clementz; Carol Tamminga; Godfrey Pearlson; John Sweeney; Matcheri S Keshavan Journal: Schizophr Res Date: 2015-04-19 Impact factor: 4.939
Authors: Rebecca F McKnight; Saïk J G N de La Motte de Broöns de Vauvert; Edward Chesney; Ben H Amit; John Geddes; Andrea Cipriani Journal: Cochrane Database Syst Rev Date: 2019-06-01
Authors: W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff Journal: Schizophr Bull Date: 2014-04 Impact factor: 9.306